Peter T. Daniel

9.8k total citations
135 papers, 8.2k citations indexed

About

Peter T. Daniel is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Peter T. Daniel has authored 135 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 57 papers in Oncology and 34 papers in Immunology. Recurrent topics in Peter T. Daniel's work include Cell death mechanisms and regulation (67 papers), Cancer-related Molecular Pathways (34 papers) and RNA Interference and Gene Delivery (14 papers). Peter T. Daniel is often cited by papers focused on Cell death mechanisms and regulation (67 papers), Cancer-related Molecular Pathways (34 papers) and RNA Interference and Gene Delivery (14 papers). Peter T. Daniel collaborates with scholars based in Germany, United States and France. Peter T. Daniel's co-authors include Bernd Dörken, Klaus Schulze‐Osthoff, Isrid Sturm, Bernhard Gillissen, Thomas Wieder, P H Krammer, Frank Eßmann, Claus Belka, Ralf C. Bargou and Jens Dhein and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Peter T. Daniel

132 papers receiving 8.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter T. Daniel Germany 53 5.2k 2.8k 1.8k 1.0k 652 135 8.2k
Aviv Gazit Israel 45 5.3k 1.0× 3.3k 1.2× 1.3k 0.7× 913 0.9× 550 0.8× 99 9.7k
Alexandru Almasan United States 45 4.4k 0.8× 1.9k 0.7× 951 0.5× 1.0k 1.0× 502 0.8× 96 6.5k
Didier Decaudin France 39 3.6k 0.7× 1.8k 0.7× 1.2k 0.6× 765 0.7× 1.2k 1.9× 148 7.0k
Fengzhi Li United States 45 6.9k 1.3× 3.2k 1.2× 1.5k 0.8× 1.1k 1.1× 445 0.7× 139 9.1k
Elaine M. Hurt United States 35 3.1k 0.6× 2.4k 0.9× 2.0k 1.1× 1.0k 1.0× 457 0.7× 59 6.3k
Klaus Podar United States 63 8.7k 1.7× 4.6k 1.6× 1.8k 1.0× 1.3k 1.2× 1.3k 2.0× 186 12.8k
Sam W. Lee United States 48 5.0k 1.0× 2.3k 0.8× 1.2k 0.7× 1.1k 1.0× 275 0.4× 93 7.1k
Joseph Lotem Israel 50 5.7k 1.1× 3.2k 1.2× 2.2k 1.2× 1.2k 1.2× 379 0.6× 111 9.4k
Chuan‐Yuan Li United States 40 3.6k 0.7× 1.6k 0.6× 1.3k 0.7× 1.4k 1.3× 271 0.4× 115 6.0k
Agostino Tafuri Italy 36 4.3k 0.8× 1.7k 0.6× 2.3k 1.2× 787 0.8× 508 0.8× 160 8.3k

Countries citing papers authored by Peter T. Daniel

Since Specialization
Citations

This map shows the geographic impact of Peter T. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T. Daniel more than expected).

Fields of papers citing papers by Peter T. Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter T. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T. Daniel. The network helps show where Peter T. Daniel may publish in the future.

Co-authorship network of co-authors of Peter T. Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of Peter T. Daniel. A scholar is included among the top collaborators of Peter T. Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter T. Daniel. Peter T. Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Anja, Chuanbing Zang, Cindrilla Chumduri, et al.. (2013). Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma. International Journal of Cancer. 133(8). 1813–1824. 40 indexed citations
2.
Plötz, Michael, Bernhard Gillissen, Amir M. Hossini, Peter T. Daniel, & Jürgen Eberle. (2012). Disruption of the VDAC2–Bak interaction by Bcl-xS mediates efficient induction of apoptosis in melanoma cells. Cell Death and Differentiation. 19(12). 1928–1938. 49 indexed citations
3.
Volčič, Meta, Sabine Karl, Bernd Baumann, et al.. (2011). NF-κB regulates DNA double-strand break repair in conjunction with BRCA1–CtIP complexes. Nucleic Acids Research. 40(1). 181–195. 112 indexed citations
4.
Haefen, Clarissa von, Jana Wendt, Marco Sifringer, et al.. (2011). Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway. APOPTOSIS. 16(6). 636–651. 18 indexed citations
5.
Zantl, Niko, Gregor Weirich, Silke Fischer, et al.. (2007). Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance. Oncogene. 26(49). 7038–7048. 71 indexed citations
6.
Fecker, Lothar F., Christoph C. Geilen, Georgi Tchernev, et al.. (2006). Loss of Proapoptotic Bcl-2-Related Multidomain Proteins in Primary Melanomas Is Associated with Poor Prognosis. Journal of Investigative Dermatology. 126(6). 1366–1371. 55 indexed citations
7.
Wendt, Jana, Silke Radetzki, Clarissa von Haefen, et al.. (2005). Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells. Oncogene. 25(7). 972–980. 63 indexed citations
8.
Hemmati, Philipp, Guillaume Normand, Berlinda Verdoodt, et al.. (2005). Loss of p21 disrupts p14ARF-induced G1 cell cycle arrest but augments p14ARF-induced apoptosis in human carcinoma cells. Oncogene. 24(25). 4114–4128. 33 indexed citations
9.
Stärck, Lilian, Christian Schölz, Bernd Dörken, & Peter T. Daniel. (2005). Costimulation by CD137/4–1BB inhibits T cell apoptosis and induces Bcl‐xL and c‐FLIPshort via phosphatidylinositol 3‐kinase and AKT/protein kinase B. European Journal of Immunology. 35(4). 1257–1266. 65 indexed citations
10.
Stärck, Lilian, Christian Schölz, Thomas Blankenstein, Bernd Dörken, & Peter T. Daniel. (2005). Necrotic death but not irradiation abolishes costimulation of T‐cell effector functions and survival by CD80‐expressing tumor cells. International Journal of Cancer. 116(1). 78–86. 2 indexed citations
11.
Radetzki, Silke, Claus‐Henning Köhne, Clarissa von Haefen, et al.. (2002). The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene. 21(2). 227–238. 3 indexed citations
12.
Radetzki, Silke, Claus‐Henning Köhne, Clarissa von Haefen, et al.. (2002). The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene. 21(2). 227–238. 52 indexed citations
13.
Hossini, Amir M., Jürgen Eberle, Christian Riebeling, et al.. (2001). The Bax/Bcl-2 Ratio Determines the Susceptibility of Human Melanoma Cells to CD95/Fas-Mediated Apoptosis. Journal of Investigative Dermatology. 117(2). 333–340. 466 indexed citations
15.
Daniel, Peter T., Christian Schölz, Frank Eßmann, et al.. (1999). CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism. Experimental Hematology. 27(9). 1402–1408. 18 indexed citations
16.
Daniel, Peter T., Christian Schölz, Juergen Westermann, Bernd Dörken, & Antonio Pezzutto. (1998). Dendritic Cells Prevent CD95 Mediated T Lymphocyte Death through Costimulatory Signals. Advances in experimental medicine and biology. 451. 173–177. 12 indexed citations
17.
Daniel, Peter T., et al.. (1997). Activation and activation‐induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO‐1) ligand expression and function. European Journal of Immunology. 27(4). 1029–1034. 31 indexed citations
18.
Wagener, Christian, Ralf C. Bargou, Peter T. Daniel, et al.. (1996). Induction of the death-promoting genebax-? sensitizes cultured breast-cancer cells to drug-induced apoptosis. International Journal of Cancer. 67(1). 138–141. 95 indexed citations
19.
Chlichlia, Katerina, Gerhard Moldenhauer, Peter T. Daniel, et al.. (1995). Immediate effects of reversible HTLV-ITax function: T-cell activation and apoptosis. Journal of Cancer Research and Clinical Oncology. 121(S1). S30–S30. 73 indexed citations
20.
Daniel, Peter T., et al.. (1981). Die In-Vitro-Verdaulichkeit als Qualitätsmerkmal bei der Sortenbeurteilung von Futtergräsern. OpenAgrar. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026